- RecruitingPHASE3
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
This study is testing a new medicine called empasiprubart for adults with a nerve condition called CIDP. It wants to see if the medicine is safe and helps people feel better. Participants will get the study medicine or a dummy medicine first, then everyone will get the study medicine.
For: Chronic Inflammatory Demyelinating Polyneuropathy · CIDP · Chronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States · Argentina · Austria - RecruitingPHASE2, PHASE3
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
This study is looking into a new medicine called efgartigimod for young people aged 12 to 17 with a blood condition called chronic ITP. The aim is to find the best dose to help increase their platelet count and manage their condition.
For: Immune Thrombocytopenia (ITP) · ITP - Immune Thrombocytopenia · ITPFrance · Germany · Italy - RecruitingPHASE2
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
This study is looking at a new medicine called ARGX-119 for children aged 5 to 17 with Spinal Muscular Atrophy (SMA). It aims to find the right dose, check how safe it is, and see how well it works alongside their current SMA treatments to help muscle strength.
For: Spinal Muscular Atrophy (SMA)United States · United Kingdom - Active not recruitingPHASE3
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
This study is testing a new medicine called efgartigimod for people with a type of Myasthenia Gravis (MG). It checks how well it works and if it's safe compared to a dummy medicine. Some people will then get the new medicine openly.
For: Generalized Myasthenia Gravis · gMG · Myasthenia Gravis, GeneralizedUnited States · Belgium · Canada - Active not recruitingPHASE2
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
This study looks at new treatments (ramucirumab or merestinib) combined with standard chemotherapy for people with advanced biliary tract cancer. It aims to see how well these new drug combinations work and if they are safe.
For: Biliary Tract Cancer · Metastatic Cancer · Advanced CancerUnited States · Argentina · Australia - RecruitingPHASE3
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
This study is testing a new medicine called efgartigimod for adults with a blood condition called primary immune thrombocytopenia (ITP). Researchers want to see if it's safe and helps increase blood platelet counts. Some people will get the study drug, others a placebo (dummy drug).
For: Primary Immune Thrombocytopenia (ITP)United States · Austria · Bulgaria